not true. According to PhRMA (“the process behind new medicines”, 2015, online) , average clinical development time (from phases1 to 3) is around 6-7 years. Total time discovery to approval 10 years. So you’re well off the mark sorry. But I guess phrma data based on companies that know what they’re doing and are actually doing stuff. 15-20 years is probably about right when you have a company that’s a scientist’s hobby with job for life md.
Ann: BIT225 HIV-1 Immunomodulatory Paper Published, page-37
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.001(3.13%) |
Mkt cap ! $27.97M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.1¢ | 3.0¢ | $21.36K | 696.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 916074 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 120000 | 2 |
View Market Depth
| Last trade - 13.55pm 30/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |